Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCLC Stage B Hepatocellular Carcinoma”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT02940496
What this trial is testing

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more
M.D. Anderson Cancer Center 15
Large-scale testing (Phase 3)UnknownNCT03642561
What this trial is testing

Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE

Who this might be right for
Hepatocellular Carcinoma
Fudan University 300
Not applicableNot Yet RecruitingNCT07807475
What this trial is testing

DNP-MRSI of HCC Metabolism to Predict Therapeutic Response

Who this might be right for
Barcelona Clinic Liver Cancer (BCLC) Stage A, B or C HCC
Abramson Cancer Center at Penn Medicine 232
Testing effectiveness (Phase 2)UnknownNCT05883176
What this trial is testing

TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 35
Not applicableNot Yet RecruitingNCT07449637
What this trial is testing

Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.

Who this might be right for
BCLC Stage B Hepatocellular Carcinoma
Sohag University 200
Not applicableStudy completedNCT06261138
What this trial is testing

Survival Analysis: TACE vs. Combination Therapy in HCC

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 279
Testing effectiveness (Phase 2)Looking for participantsNCT07154082
What this trial is testing

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Wei Zhang 27
Testing effectiveness (Phase 2)WithdrawnNCT03775707
What this trial is testing

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Who this might be right for
Hepatocellular Carcinoma
Shi Ming
Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Not applicableUnknownNCT04424043
What this trial is testing

Neo-TACE-HAIC for BCLC B Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 280
Not applicableUnknownNCT02616926
What this trial is testing

Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 538
Early research (Phase 1)Enrolling By InvitationNCT06882876
What this trial is testing

JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Xiangya Hospital of Central South University 20
Testing effectiveness (Phase 2)Study completedNCT04828486
What this trial is testing

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+2 more
Mayo Clinic 14
Testing effectiveness (Phase 2)Ended earlyNCT04442581
What this trial is testing

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
University of Washington 2
Not applicableLooking for participantsNCT07436845
What this trial is testing

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)Emotional DistressHAIC(Hepatic Artery Infusion Chemotherapy)+2 more
Nanfang Hospital, Southern Medical University 90
Early research (Phase 1)Study completedNCT01666756
What this trial is testing

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Adult Hepatocellular Carcinoma+2 more
City of Hope Medical Center 18
Large-scale testing (Phase 3)UnknownNCT04909866
What this trial is testing

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Next Page